Glucagon-Like Peptide-1 Receptor Agonists: Best Choice for Patients With Cirrhosis and Diabetes?

Glucagon-Like Peptide-1 Receptor Agonists: Best Choice for Patients With Cirrhosis and Diabetes?

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical gastroenterology and hepatology 2024-05, Vol.22 (5), p.1142-1143
Hauptverfasser: Li, Yuanyuan, Wang, Xiaoze
Format: Artikel
Sprache:eng
Schlagworte:
Diabetes Mellitus - drug therapy
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - drug therapy
Glucagon-Like Peptide-1 Receptor Agonists - therapeutic use
Humans
Hypoglycemic Agents - therapeutic use
Liver Cirrhosis - complications
Liver Cirrhosis - drug therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1143
container_issue 5
container_start_page 1142
container_title Clinical gastroenterology and hepatology
container_volume 22
creator Li, Yuanyuan
Wang, Xiaoze
description
doi_str_mv 10.1016/j.cgh.2023.08.012
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2860615681</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1542356523006614</els_id><sourcerecordid>2860615681</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-df14cdae83f200b8794fc8f9c9251267e91f1e330881473a77f72a36f1f5ee6b3</originalsourceid><addsrcrecordid>eNp9kM1PGzEQxS0E4vsP4IJ85LKLx961vfRQ0ZQvKRKoatWjcbxj4pBkU9up1P--RgkcOc2T5r2nmR8hZ8BqYCAvZ7V7mdaccVEzXTPgO-QQ2oZXSkGzu9Wile0BOUppxhjvmk7tkwOhpGRK6kPyfDdfO_syLKtxeEX6hKsceqyA_kBX9BDpdVmGlNMV_YYp09F0CA6pL5snmwMuc6K_Q57SUYhxOqSQqF329HuwE8yYvp6QPW_nCU-385j8ur35Obqvxo93D6PrceVEK3LVe2hcb1ELzxmbaNU13mnfuY63wKXCDjygEExraJSwSnnFrZAefIsoJ-KYXGx6V3H4sy6XmkVIDudzu8RhnQzXkklopYZihY3VxSGliN6sYljY-M8AM29gzcwUsOYNrGHaFLAlc76tX08W2H8k3kkWw5eNAcuTfwNGk1yh47APEV02_RA-qf8PlQGH1g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2860615681</pqid></control><display><type>article</type><title>Glucagon-Like Peptide-1 Receptor Agonists: Best Choice for Patients With Cirrhosis and Diabetes?</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Li, Yuanyuan ; Wang, Xiaoze</creator><creatorcontrib>Li, Yuanyuan ; Wang, Xiaoze</creatorcontrib><identifier>ISSN: 1542-3565</identifier><identifier>ISSN: 1542-7714</identifier><identifier>EISSN: 1542-7714</identifier><identifier>DOI: 10.1016/j.cgh.2023.08.012</identifier><identifier>PMID: 37660768</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Diabetes Mellitus - drug therapy ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - drug therapy ; Glucagon-Like Peptide-1 Receptor Agonists - therapeutic use ; Humans ; Hypoglycemic Agents - therapeutic use ; Liver Cirrhosis - complications ; Liver Cirrhosis - drug therapy</subject><ispartof>Clinical gastroenterology and hepatology, 2024-05, Vol.22 (5), p.1142-1143</ispartof><rights>2024 AGA Institute</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-df14cdae83f200b8794fc8f9c9251267e91f1e330881473a77f72a36f1f5ee6b3</citedby><cites>FETCH-LOGICAL-c353t-df14cdae83f200b8794fc8f9c9251267e91f1e330881473a77f72a36f1f5ee6b3</cites><orcidid>0000-0002-7169-9467</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.cgh.2023.08.012$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37660768$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Yuanyuan</creatorcontrib><creatorcontrib>Wang, Xiaoze</creatorcontrib><title>Glucagon-Like Peptide-1 Receptor Agonists: Best Choice for Patients With Cirrhosis and Diabetes?</title><title>Clinical gastroenterology and hepatology</title><addtitle>Clin Gastroenterol Hepatol</addtitle><subject>Diabetes Mellitus - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Glucagon-Like Peptide-1 Receptor Agonists - therapeutic use</subject><subject>Humans</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Liver Cirrhosis - complications</subject><subject>Liver Cirrhosis - drug therapy</subject><issn>1542-3565</issn><issn>1542-7714</issn><issn>1542-7714</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1PGzEQxS0E4vsP4IJ85LKLx961vfRQ0ZQvKRKoatWjcbxj4pBkU9up1P--RgkcOc2T5r2nmR8hZ8BqYCAvZ7V7mdaccVEzXTPgO-QQ2oZXSkGzu9Wile0BOUppxhjvmk7tkwOhpGRK6kPyfDdfO_syLKtxeEX6hKsceqyA_kBX9BDpdVmGlNMV_YYp09F0CA6pL5snmwMuc6K_Q57SUYhxOqSQqF329HuwE8yYvp6QPW_nCU-385j8ur35Obqvxo93D6PrceVEK3LVe2hcb1ELzxmbaNU13mnfuY63wKXCDjygEExraJSwSnnFrZAefIsoJ-KYXGx6V3H4sy6XmkVIDudzu8RhnQzXkklopYZihY3VxSGliN6sYljY-M8AM29gzcwUsOYNrGHaFLAlc76tX08W2H8k3kkWw5eNAcuTfwNGk1yh47APEV02_RA-qf8PlQGH1g</recordid><startdate>202405</startdate><enddate>202405</enddate><creator>Li, Yuanyuan</creator><creator>Wang, Xiaoze</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7169-9467</orcidid></search><sort><creationdate>202405</creationdate><title>Glucagon-Like Peptide-1 Receptor Agonists: Best Choice for Patients With Cirrhosis and Diabetes?</title><author>Li, Yuanyuan ; Wang, Xiaoze</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-df14cdae83f200b8794fc8f9c9251267e91f1e330881473a77f72a36f1f5ee6b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Diabetes Mellitus - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Glucagon-Like Peptide-1 Receptor Agonists - therapeutic use</topic><topic>Humans</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Liver Cirrhosis - complications</topic><topic>Liver Cirrhosis - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Yuanyuan</creatorcontrib><creatorcontrib>Wang, Xiaoze</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical gastroenterology and hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Yuanyuan</au><au>Wang, Xiaoze</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glucagon-Like Peptide-1 Receptor Agonists: Best Choice for Patients With Cirrhosis and Diabetes?</atitle><jtitle>Clinical gastroenterology and hepatology</jtitle><addtitle>Clin Gastroenterol Hepatol</addtitle><date>2024-05</date><risdate>2024</risdate><volume>22</volume><issue>5</issue><spage>1142</spage><epage>1143</epage><pages>1142-1143</pages><issn>1542-3565</issn><issn>1542-7714</issn><eissn>1542-7714</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>37660768</pmid><doi>10.1016/j.cgh.2023.08.012</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-7169-9467</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1542-3565
ispartof Clinical gastroenterology and hepatology, 2024-05, Vol.22 (5), p.1142-1143
issn 1542-3565
1542-7714
1542-7714
language eng
recordid cdi_proquest_miscellaneous_2860615681
source MEDLINE; Elsevier ScienceDirect Journals
subjects Diabetes Mellitus - drug therapy
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - drug therapy
Glucagon-Like Peptide-1 Receptor Agonists - therapeutic use
Humans
Hypoglycemic Agents - therapeutic use
Liver Cirrhosis - complications
Liver Cirrhosis - drug therapy
title Glucagon-Like Peptide-1 Receptor Agonists: Best Choice for Patients With Cirrhosis and Diabetes?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T01%3A05%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glucagon-Like%20Peptide-1%20Receptor%20Agonists:%20Best%20Choice%20for%20Patients%20With%20Cirrhosis%20and%20Diabetes?&rft.jtitle=Clinical%20gastroenterology%20and%20hepatology&rft.au=Li,%20Yuanyuan&rft.date=2024-05&rft.volume=22&rft.issue=5&rft.spage=1142&rft.epage=1143&rft.pages=1142-1143&rft.issn=1542-3565&rft.eissn=1542-7714&rft_id=info:doi/10.1016/j.cgh.2023.08.012&rft_dat=%3Cproquest_cross%3E2860615681%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2860615681&rft_id=info:pmid/37660768&rft_els_id=S1542356523006614&rfr_iscdi=true